Operational insight · No jargon
Analysis and practical guides for the cleantech ecosystem
Commercial development, fundraising, water, decarbonisation — written for teams making decisions, not for teams commissioning reports.
Why the first commercial contract is often harder to secure than a seed round. The pilot trap, four recurring bottlenecks, and a 90-day sprint to move from zero pipeline to a signed letter of intent.
Why cleantech is structurally different from SaaS in the eyes of investors. The three questions every deeptech fund asks first.
The six building blocks of an executable GTM model — precise ICP, rigorous market sizing, channel strategy, value-based pricing, sales enablement, and a 90-day execution plan.
Technical validation does not guarantee commercial validation. What separates a strong prototype from a product that customers are actually ready to buy.
South Korea's industrial base, its government-backed green tech programmes, and how Korean certifications are becoming global market references.
The three regulatory frameworks turning decarbonisation from an ESG commitment into a real procurement imperative — and what that means for your supplier base.
The PFAS thresholds now coming into force, the industrial sectors most exposed, and the treatment technologies already available today.
How to calculate the true ROI of an energy efficiency investment, structure the upstream audit properly, and use CEE financing to reduce upfront cost.
Industrial heat accounts for 20% of EU emissions. A comparative view of the technologies already available, by temperature range and industrial use case.
Which parameters should be tracked in real time, how to integrate sensors with existing SCADA infrastructure, and the business case for predictive maintenance in water treatment.
Where capital is concentrating in 2026, why industrial decarbonisation is attracting the strongest wave of investment, and which commercial signals separate fundable companies from the rest.
Steel, cement, chemicals, glass — emissions profiles, CBAM as a demand-creation mechanism, and how to assess the commercial maturity of an industrial deeptech company.
Why the Drinking Water Directive is creating an unprecedented level of purchasing certainty, which technology subcategories are capturing value, and what the Korean case reveals.
The technology-first bias, the five dimensions of commercial maturity, and the red and green flags in a deeptech founder's pitch.
The risks of relying on a single market, how to build an international scaling playbook, and why expansion is a real value-creation lever at exit.
A full overview of the financing options available, their underlying logic, and how to build the right mix between dilutive and non-dilutive capital.
A comparison of six treatment technologies — PFAS performance, capex and opex profile, deployment timelines, and industrial use cases.
A comparative analysis of four technology families through the lens of commercial risk, revenue profile, and barriers to industrial adoption.
The seven steps required to build a pipeline from scratch — ICP, target account list, DMU mapping, outreach sequencing, MEDDIC qualification, and stage-based management.
The baseline work required upstream, the eight stages of the RFP process, the evaluation criteria that should be defined before launch, and the six contractual clauses that protect the buyer.